These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25099590)

  • 1. Fibrinolysis for intermediate-risk pulmonary embolism.
    Meyer G; Vicaut E; Konstantinides SV
    N Engl J Med; 2014 Aug; 371(6):581-2. PubMed ID: 25099590
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis for intermediate-risk pulmonary embolism.
    Nobre C; Thomas B
    N Engl J Med; 2014 Aug; 371(6):580. PubMed ID: 25099594
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis for intermediate-risk pulmonary embolism.
    Smulders Y; Kramers C
    N Engl J Med; 2014 Aug; 371(6):579. PubMed ID: 25099591
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis for intermediate-risk pulmonary embolism.
    Girerd N; Rossignol P; Zannad F
    N Engl J Med; 2014 Aug; 371(6):579. PubMed ID: 25099592
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis for intermediate-risk pulmonary embolism.
    Elliott CG
    N Engl J Med; 2014 Aug; 371(6):582. PubMed ID: 25105191
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis for intermediate-risk pulmonary embolism.
    Spiegel RJ; Nickson CP; Radecki RP
    N Engl J Med; 2014 Aug; 371(6):581. PubMed ID: 25099596
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolysis for intermediate-risk pulmonary embolism.
    Porres-Aguilar M; Mukherjee D
    N Engl J Med; 2014 Aug; 371(6):580-1. PubMed ID: 25099595
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment on "Fibrinolysis for patients with intermediate-risk pulmonary embolism"].
    Castro Mda G
    Rev Port Cardiol; 2014 Oct; 33(10):663-4. PubMed ID: 25594091
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis for intermediate-risk pulmonary embolism.
    Gonzalez E; Moore HB; Moore EE
    N Engl J Med; 2014 Aug; 371(6):579-80. PubMed ID: 25099593
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous thromboembolism: High incidence of bleeding with fibrinolysis in intermediate-risk pulmonary embolism.
    Lim GB
    Nat Rev Cardiol; 2014 Jun; 11(6):312. PubMed ID: 24776705
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis of pulmonary emboli--steer closer to Scylla.
    Elliott CG
    N Engl J Med; 2014 Apr; 370(15):1457-8. PubMed ID: 24716686
    [No Abstract]   [Full Text] [Related]  

  • 12. In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.
    Akl EA; Guyatt GH
    Ann Intern Med; 2014 Sep; 161(6):JC8-9. PubMed ID: 25222420
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Ajani AE; Waksman R
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542063
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery.
    Zencirkiran Agus H; Uygur B; Guler A; Demirci G; Kalkan AK; Yildiz M
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):559-561. PubMed ID: 29985194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis for pulmonary embolism.
    Goldhaber SZ
    N Engl J Med; 2002 Oct; 347(15):1131-2. PubMed ID: 12374871
    [No Abstract]   [Full Text] [Related]  

  • 16. Early lytic treatment of massive pulmonary embolism.
    Cardiovasc J S Afr; 2002; 13(4):218-9. PubMed ID: 12402933
    [No Abstract]   [Full Text] [Related]  

  • 17. [The PEITHO study].
    Alunni G; Coen D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):591-5. PubMed ID: 25424135
    [No Abstract]   [Full Text] [Related]  

  • 18. [The place of lysis in acute pulmonary embolism].
    Olschewski H
    Zentralbl Chir; 2006 Oct; 131(5):432-4. PubMed ID: 17089298
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
    Hourmouzis Z; Bhalla MC; Frey JA; Jwayyed S
    Am J Emerg Med; 2015 May; 33(5):739.e5-6. PubMed ID: 25497698
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pulmonary embolism: could thrombolysis be extended to patients with intermediate-risk pulmonary embolism?].
    Bouzerda A; Serghini I; Kharass AE
    Pan Afr Med J; 2017; 26():238. PubMed ID: 28690752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.